mRNA expression
Gene:
GAGE1 (official gene symbol)
Other symbol:
GAGE1
CT family:
CT4
CT identifier:
CT4.1
Aliases from NCBI:
MGC33825
Unified entry for genes GAGE1, GAGE12B, GAGE12C, GAGE12D, GAGE12E, GAGE12F, GAGE12G, GAGE12H, GAGE12I, GAGE12J, GAGE13, GAGE2A, GAGE4, GAGE5, GAGE6, GAGE7, GAGE8 (nearly-identical copies)
Gene expression pattern ? : Testis/brain-restricted
High-throughput data (expression in cancer samples)
SAGE(short, 10 nt tags) Show
SAGE(long, 17 nt tags) Show
MPSS (short, 13 nt tags) Show
EST Show
Published data of mRNA expression in normal tissues
Show
Published data of mRNA expression in neoplasias
Hematologic malignacies Show
| Tumor Subtype |
Sample type |
Frequency |
Methodology |
PMID |
Myeloma
|
|
13/39 (36%) |
RT-PCR |
18237105
|
Myeloma
|
Newly diagnosed patient |
53/320 (17%) |
Microarray |
21738656
|
Myeloma
|
Relapse patient |
188/264 (71%) |
Microarray |
Brain cancer Show
| Tumor Subtype |
Sample type |
Frequency |
Methodology |
PMID |
Ependymoma (Pediatric)
|
|
13/14 (93%) |
RT-PCR |
10037183
|
Glioblastoma multiforme
|
|
13/20 (65%) |
RT-PCR |
Glioblastoma multiforme (Pediatric)
|
|
7/9 (78%) |
RT-PCR |
Medulloblastoma (Pediatric)
|
|
7/15 (47%) |
RT-PCR |
Medulloblastoma (Pediatric)
|
|
2/11 (18%) |
qRT-PCR |
18398575
|
Medulloblastomas
|
|
16/25 (64%) |
RT-PCR |
18426187
|
Colon & Rectum cancer Show
| Tumor Subtype |
Sample type |
Frequency |
Methodology |
PMID |
Adenocarcinoma of the large intestine
|
|
0/78 (0%) |
qRT-PCR |
23390371
|
Head & Neck cancer Show
| Tumor Subtype |
Sample type |
Frequency |
Methodology |
PMID |
Squamous cell carcinoma
|
Primary tumor |
9/57 (16%) |
RT-PCR |
20715104
|
Hepatobiliary cancer Show
| Tumor Subtype |
Sample type |
Frequency |
Methodology |
PMID |
Hepatocellular carcinoma
|
|
12/33 (33%) |
RT-PCR |
10782910
|
Lung cancer Show
| Tumor Subtype |
Sample type |
Frequency |
Methodology |
PMID |
Non small cell lung carcinoma
|
|
18/77 (23%) |
RT-PCR |
7544395
|
Adenocarcinoma
|
|
15/42 (36%) |
RT-PCR |
10397259
|
Squamous cell carcinoma
|
|
87/211 (41%) |
RT-PCR |
Melanocytic lesion Show
| Tumor Subtype |
Sample type |
Frequency |
Methodology |
PMID |
Melanoma
|
Primary tumor |
5/39 (13%) |
RT-PCR |
7544395
|
Melanoma
|
Metastatic tumor |
47/130 (36%) |
RT-PCR |
Melanoma
|
|
0/10 (0%) |
RT-PCR |
12190937
|
Melanoma
|
Primary tumor |
23/79 (29%) |
RT-PCR |
10397259
|
Melanoma
|
Metastatic tumor |
87/211 (41%) |
RT-PCR |
Ovarian cancer Show
| Tumor Subtype |
Sample type |
Frequency |
Methodology |
PMID |
Ovarian carcinoma
|
Peritoneal fluid |
8/27 (30%) |
RT-PCR |
12115308
|
Testicular cancer Show
| Tumor Subtype |
Sample type |
Frequency |
Methodology |
PMID |
Seminoma
|
|
6/6 (100%) |
RT-PCR |
7544395
|
Published data of mRNA expression in Cell Lines
Show
| Origin tissue |
Cell Line ID |
Frequency |
Methodology |
PMID |
| Embryonal carcinoma | NTERA2 |
| Western blot |
23029259 |
| Hepatocellular carcinoma | BEL-74-2 |
1/3 (33%) | RT-PCR |
14607688 |
| Lung carcinoma-SCLC | |
4/11 (36%) | RT-PCR |
9415308 |
| Melanoma | WM115-A
WM1972-A
WM1976-A
WM3130-A |
4/4 (100%) | RT-PCR |
18205182 |
| Melanoma | MZ2-MEL.3.0
MI13443-MEL |
2/6 (33%) | Northern blot |
7544395 |
| Melanoma stem cells (MSC) | WM115-NA
WM1972-NA
WM1976-NA
WM3130-NA |
4/4 (100%) | RT-PCR |
18205182 |
| Myeloma | SBN
XG2
XG6
XG7
AMO-1
Karpas
620
NCI-H929
U266 |
8/17 (47%) | RT-PCR |
10741395 |
| Nullipotent teratocarcinoma | PA-1 |
| RT-PCR |
21785609 |
| Osteosarcoma | U-2OS
|
| RT-PCR |
21785609 |
| Pluripotent stem cells | SC5
SC7
SC3a
|
| RT-PCR |
21785609 |
